Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mahoney

Showing results (751-760 of 775) with videos related to

Pageof 78
Sort By:
NPJ Vaccines|January 9, 2025
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infectionJun Liu, Li Wang, Alexandra Kurtesi, et al.
Science Immunology|November 1, 2024
The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cellsGerone A Gonzales, Song Huang, Liam Wilkinson, et al.
American Journal of Human Genetics|February 26, 2013
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK populationJon Beck, Mark Poulter, Davina Hensman, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
A bioinformatics screen reveals Hox and chromatin remodeling factors at the <i>Drosophila</i> histone locusLauren J Hodkinson, Connor Smith, H Skye Comstra, et al.
BMC Genomic Data|September 22, 2023
A bioinformatics screen reveals hox and chromatin remodeling factors at the Drosophila histone locusLauren J Hodkinson, Connor Smith, H Skye Comstra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2014
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementiaCatherine F Slattery, Jonathan A Beck, Lorna Harper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screenZaid Taha, Rozanne Arulanandam, Glib Maznyi, et al.
Nature Communications|May 27, 2023
macroH2A2 antagonizes epigenetic programs of stemness in glioblastomaAna Nikolic, Francesca Maule, Anna Bobyn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Nikolas T Martin, et al.
Critical Care Explorations|March 16, 2022
Characteristics of Post-ICU and Post-COVID Recovery Clinics in 29 U.S. Health SystemsValerie Danesh, Leanne M Boehm, Tammy L Eaton, et al.
Pageof 78

Showing results (751-760 of 775) with videos related to

Sort By:
Pageof 78
NPJ Vaccines|January 9, 2025
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infectionJun Liu, Li Wang, Alexandra Kurtesi, et al.
Science Immunology|November 1, 2024
The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cellsGerone A Gonzales, Song Huang, Liam Wilkinson, et al.
American Journal of Human Genetics|February 26, 2013
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK populationJon Beck, Mark Poulter, Davina Hensman, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
A bioinformatics screen reveals Hox and chromatin remodeling factors at the <i>Drosophila</i> histone locusLauren J Hodkinson, Connor Smith, H Skye Comstra, et al.
BMC Genomic Data|September 22, 2023
A bioinformatics screen reveals hox and chromatin remodeling factors at the Drosophila histone locusLauren J Hodkinson, Connor Smith, H Skye Comstra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2014
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementiaCatherine F Slattery, Jonathan A Beck, Lorna Harper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screenZaid Taha, Rozanne Arulanandam, Glib Maznyi, et al.
Nature Communications|May 27, 2023
macroH2A2 antagonizes epigenetic programs of stemness in glioblastomaAna Nikolic, Francesca Maule, Anna Bobyn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Nikolas T Martin, et al.
Critical Care Explorations|March 16, 2022
Characteristics of Post-ICU and Post-COVID Recovery Clinics in 29 U.S. Health SystemsValerie Danesh, Leanne M Boehm, Tammy L Eaton, et al.
Pageof 78